Loading Complete
Neeha Zaidi

Neeha Zaidi, MD

Medical Oncology

Accepting New Patients

Highlights

Languages

  • English

Gender

Female

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Neeha Zaidi

Primary Academic Title

Associate Professor of Oncology

Background

Dr. Neeha Zaidi is a physician scientist and a medical oncologist, caring for patients with pancreatic and colorectal cancers.

Dr. Zaidi received her undergraduate degree (Magna Cum Laude) in Biology from Cornell University and earned her M.D. from the Mount Sinai School of Medicine where she graduated with Distinction in Research. During medical school, she spent a year as a Howard Hughes Medical Institute (HHMI) Research Fellow at The Rockefeller University studying dendritic cell vaccines. She completed her residency in internal medicine at Weill Cornell and subsequently received an Intramural Research Training Award to perform a year-long post-doctoral fellowship at the Vaccine Research Center (NIAID) at the NIH. She then completed a fellowship in medical oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. Zaidi joined the Johns Hopkins faculty in 2019.

Dr. Zaidi’s laboratory focuses on developing novel personalized immunotherapy approaches for the treatment and prevention of pancreatic cancer.

Dr. Zaidi has most recently been recognized with an ASCO Career Development Award and a NCI K08 Award.

Selected Publications

  • Zaidi N, Quezada S, Kuroiwa JM, Zhang L, Jaffee EM, Steinman RM, Wang B (2019) Anti-CTLA-4 therapy synergizes with dendritic cell targeting vaccines to promote effector T cell infiltration in an IL-3–dependent manner.  Annals of the New York Academy of Sciences 1445: 62-73. PMID: 30954313

  • Zaidi N, Soban M, Chen F, Mathew J, Kinkead, HL, Armstrong TA, Haider S, Jaffee EM (2020) Role of in silico structural modeling in predicting immunogenic neoepitopes for cancer vaccine development. (2020) JCI Insight 5(17): 136911. PMID: 32879142

  • Kinkead HL, Hopkins A, Lutz E, Wu AA, Yarchoan M, Cruz K, Woolman S, Vithayathil T, Glickman LH, Ndubaku CO, McWhirter SM, Dubensky TW Jr, Armstrong TD, Jaffee EM*, Zaidi N*. (2018) Combining STING–based neoantigen–targeted vaccine with checkpoint modulators enhances anti–tumor immunity in murine pancreatic cancer.  JCI Insight 3 (20): pii: 122857. PMID: 30333318. [*EMJ and NZ Corresponding Authors].

  • Lynn  GM, Sedlik C, Baharom F, Zhu Y, Ramirez-Valdez RA, Coble VL, Tobin K, Nichols SR, Itzkowitz Y, Zaidi N, Gammon JM, Blobel NJ, Denizeau J, de la Rochere P, Francica BJ, Decker B, Maciejewski M, Cheung J, Yamane H, Smelkinson MG, Francica JR, Laga R, Bernstock JD, Seymour LW, Drake CG, Jewell CM, Lantz O, Piaggio E, Ishizuka AS, Seder RA. (2020) Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens. Nature Biotechnology 38: 320-332.  PMID: 31932728

  • Sohal DPS, Kennedy EB, Cinar P, Conroy T, Copur MS, Crane CH, Garrido-Laguna I, Lau MW, Johnson T, Krishnamurthi S, Moravek C, O’Reilly EM, Philip PA, Pant S, Shah MA, Sahai V, Uronis HE, Zaidi N, Laheru D. Metastatic Pancreatic Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 2020. PMID: 32755482

Honors

  • Career Development Award, ASCO
  • NCI K08 Career Development Award
  • Career Enhancement Award, GI SPORE, 11/1/19
  • Young Investigator Award, American Society of Clinical Oncology, 7/1/18
  • The Linda Rubin Fellowship in Pancreatic Cancer Research and Patient Care (2nd recipient), Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 7/1/18
  • Member of ASCO Expert Panel for Metastatic Pancreatic Cancer Guidelines, American Society of Clinical Oncology, 7/1/18
  • Young Investigator, Stand Up 2 Cancer, 9/1/17
  • Inaugural PSTP Scholar, Physician-Scientist Training Program, Johns Hopkins University School of Medicine, 7/1/17
  • Intramural Research Training Award, National Institute of Health, 7/1/15
  • Distinction in Research, Mount Sinai School of Medicine, 5/1/15
  • Jeffrey Modell Clinical Immunology Prize, Mount Sinai School of Medicine, 5/1/12
  • American Physician-Scientist Association (APSA) Annual Meeting Travel Award, Joint ASCI-AAP-APSA Meeting, 4/1/12
  • Howard Hughes Medical Research Fellow, HHMI, 7/1/11
  • Magna Cum Laude, Cornell University, 5/1/07
  • Dean's List, Cornell University, 7/1/05

Memberships

  • American Society of Cancer Oncology,

    Member

  • American Association of Cancer Research,

    Member

  • American Physician‚ÄìScientist Association,

    Member

Locations

  1. Skip Viragh Outpatient Cancer Center
    • 201 North Broadway Street, Viragh BLDG 5th FL, Baltimore, MD 21287

    Expertise

    Education

    Johns Hopkins University School of Medicine

    Fellowship, Oncology, 2019

    New York-Presbyterian Weill Cornell

    Residency, Internal Medicine, 2015

    Mount Sinai School of Medicine

    Medical Education, MD, 2012

    Board Certifications

    Internal Medicine

    American Board of Internal Medicine, 2015

    Insurance

    Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
    Search plans
    • Aetna
    • CareFirst
    • Cigna
    • First Health
    • Geisinger Health Plan
    • HealthSmart/Accel
    • Humana
    • Johns Hopkins Health Plans
    • MultiPlan
    • Pennsylvania's Preferred Health Networks (PPHN)
    • Point Comfort Underwriters
    • Private Healthcare Systems (PHCS)
    • UnitedHealthcare
    • Veteran Affairs Community Care Network (Optum-VACCN)